Showing results (81-90 of 153) with videos related to
Sort By:
Pageof 16
Nature Genetics|November 21, 2024
Genome-wide association study reveals mechanisms underlying dilated cardiomyopathy and myocardial resilienceSean J Jurgens, Joel T Rämö, Daria R Kramarenko, et al.Journal of Thrombosis and Haemostasis : JTH|January 30, 2023
DNA methylation analysis is used to identify novel genetic loci associated with circulating fibrinogen levels in bloodJulie Hahn, Jan Bressler, Arce Domingo-Relloso, et al.Plos One|June 1, 2011
A comprehensive evaluation of potential lung function associated genes in the SpiroMeta general population sampleMa'en Obeidat, Louise V Wain, Nick Shrine, et al.Blood|August 18, 2019
Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolismSara Lindström, Lu Wang, Erin N Smith, et al.Science (New York, N.Y.)|July 18, 2024
Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran ProgramAnurag Verma, Jennifer E Huffman, Alex Rodriguez, et al.Plos One|May 11, 2019
Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart diseaseCavin K Ward-Caviness, Paul S de Vries, Kerri L Wiggins, et al.Medrxiv : the Preprint Server for Health Sciences|July 10, 2023
Diversity and Scale: Genetic Architecture of 2,068 Traits in the VA Million Veteran ProgramAnurag Verma, Jennifer E Huffman, Alex Rodriguez, et al.Medrxiv : the Preprint Server for Health Sciences|August 30, 2023
Rare damaging <i>CCR2</i> variants are associated with lower lifetime cardiovascular riskMarios K Georgakis, Rainer Malik, Omar El Bounkari, et al.Circulation|April 20, 2011
Genetic predictors of fibrin D-dimer levels in healthy adultsNicholas L Smith, Jennifer E Huffman, David P Strachan, et al.Genome Medicine|March 22, 2025
Rare damaging CCR2 variants are associated with lower lifetime cardiovascular riskMarios K Georgakis, Rainer Malik, Omar El Bounkari, et al.Pageof 16